NORTH AMERICA PRECISION MEDICINE MARKET FORECAST 2021-2028

The North America precision medicine market is anticipated to progress with a CAGR of 9.67%, during the forecast period of 2021 to 2028. Factors such as the initiatives undertaken by the government and the increased focus of established diagnostics manufacturers, in terms of expanding their portfolio in NGS-based molecular diagnostics, are expected to facilitate the region’s market growth.

north-america-precision-medicine-market

The North America precision medicine market growth is evaluated through the analysis of the United States and Canada. The United States has launched several initiatives over the last ten years, for encouraging and promoting precision medicine. For instance, a research program named Precision Medicine Initiative Cohort Program was established in 2015, with $130 million in funding. The program’s chief objective entails advances in tailoring medical care to individuals. In 2016, the project was renamed, ‘All of Us,’ and is presently bilingual, with the material and information available in English as well as Spanish.

Likewise, Sync for ScienceWeb Site Disclaimers (S4S), was launched in 2016. As a public-private collaboration, it develops a simple, secure, and scalable approach for individuals to share and access their healthcare data with scientific researchers, supporting the ‘All of Us’ research program. Also, Sync for Genes, launched in 2017, aims to effectively standardize genome information sharing among researchers, providers, patients, and laboratories. Hence, these factors are projected to fuel the market growth in the United States, over the forecast period.

NanoString Technologies, headquartered in Seattle, the United States, is a publicly-held provider of life science tools, primarily for molecular diagnostics and translational research. Its technology enables a diverse range of translational medicine, basic research, and in-vitro diagnostics applications. The company’s products are built on an innovative digital molecular barcoding technology, developed at the Institute for Systems Biology (ISB), Seattle.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. DEVELOPMENT OF PRECISION MEDICINE
    2. KEY DRIVERS
      1. USAGE OF DIGITAL COLLABORATION IN EXCHANGING USEFUL INFORMATION FOR THE DEVELOPMENT OF PRECISION MEDICINE
      2. IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL GENES IN THE HUMAN GENOME
      3. INVESTMENTS BY GOVERNMENT AND PRIVATE PLAYERS TO FIND EFFECTIVE TREATMENT FOR DIFFERENT TYPES OF CANCERS
      4. PREVALENCE OF PRECISION MEDICINE TO TACKLE CHRONIC CONDITIONS
      5. DEMAND FOR PREVENTIVE CARE
    3. KEY RESTRAINTS
      1. SECURITY RISKS ASSOCIATED WITH DATA SHARING
      2. DIFFICULTY IN ACQUIRING PHARMACOTHERAPY APPROVAL FOR A NEW DRUG
      3. UNCERTAINTY ASSOCIATED WITH REIMBURSEMENT AND REGULATORY POLICIES
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
    2. KEY INVESTMENT INSIGHTS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRIES
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
    6. TECHNOLOGIES RELATED TO PRECISION MEDICINE
    7. SUPPLY CHAIN ANALYSIS
    8. REGULATORY FRAMEWORK
  5. MARKET BY APPLICATION
    1. ONCOLOGY
    2. INFECTIOUS DISEASES
    3. NEUROLOGY/PHYSIATRY
    4. CARDIOVASCULAR
    5. LIFESTYLE AND ENDOCRINOLOGY
    6. GASTROENTEROLOGY
    7. OTHER APPLICATIONS
  6. MARKET BY COMPONENT
    1. APPLIED SCIENCE
      1. GENOMICS
        1. PCR
        2. PM NGS
        3. GENOME EDITING
        4. OTHER GENOMICS TECHNOLOGIES
      2. PHARMACOGENOMICS
      3. OTHER APPLIED SCIENCES
    2. PRECISION THERAPEUTICS
      1. CLINICAL TRIALS
      2. CELL THERAPY
      3. DRUG DISCOVERY AND RESEARCH
      4. GENE THERAPY
    3. PRECISION DIAGNOSTICS
      1. MOLECULAR DIAGNOSTICS
        1. NON-INVASIVE PRENATAL TESTING (NIPT)
        2. COMPANION DIAGNOSTICS
        3. LIQUID BIOPSY
        4. OTHER MOLECULAR DIAGNOSTICS
      2. MEDICAL IMAGING
        1. IMAGING ANALYTICS
        2. IMAGING COMPUTER-AIDED DETECTION (CADX)
    4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
      1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
      2. BIG DATA ANALYTICS
      3. IT INFRASTRUCTURE
      4. GENOMICS INFORMATICS
      5. IN-SILICO INFORMATICS
      6. MOBILE HEALTH
  7. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. ASTRA ZENECA PLC
      3. BIOCRATES LIFE SCIENCES AG
      4. BIO-RAD LABORATORIES INC
      5. DANAHER CORPORATION
      6. EAGLE GENOMICS LTD
      7. ELI LILLY & COMPANY
      8. F. HOFFMANN-LA ROCHE
      9. INTOMICS
      10. LABORATORY CORPORATION OF AMERICA HOLDINGS
      11. NANOSTRING TECHNOLOGIES
      12. NOVARTIS AG
      13. PFIZER INC
      14. QIAGEN NV
      15. QUEST DIAGNOSTICS INCORPORATED
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE

TABLE 2: NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: NORTH AMERICA APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: NORTH AMERICA GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: NORTH AMERICA MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: LEADING PLAYERS OPERATING IN NORTH AMERICA PRECISION MEDICINE MARKET

TABLE 23: LIST OF MERGERS & ACQUISITIONS

TABLE 24: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 25: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 26: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: CHRONIC CONDITIONS IN PATIENTS HOSPITALIZED WITH COVID-19 IN THE UNITED STATES

FIGURE 2: KEY INVESTMENT INSIGHTS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, IN 2020

FIGURE 7: NORTH AMERICA PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS,2021-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, IN 2020

FIGURE 15: NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA GENOMICS MARKET, BY PM NGS, 2021-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA GENOMICS MARKET, BY GENOME EDITING, 2021-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA GENOMICS MARKET, BY OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)

FIGURE 22: BIOMARKER’S ROLE IN PHARMACOGENOMICS

FIGURE 23: NORTH AMERICA APPLIED SCIENCES MARKET, BY OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 29: NORTH AMERICA PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 30: NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 31: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)

FIGURE 32: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 33: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)

FIGURE 34: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 35: NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)

FIGURE 36: NORTH AMERICA MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)

FIGURE 37: NORTH AMERICA MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)

FIGURE 38: NORTH AMERICA PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 39: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)

FIGURE 40: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)

FIGURE 41: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)

FIGURE 42: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 43: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 44: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 45: NORTH AMERICA PRECISION MEDICINE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 46: UNITED STATES PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: CANADA PRECISION MEDICINE MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample